Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Cristina Drugan, Tudor C. Drugan, Paula Grigorescu-Sido & Ioana Naşcu. (2017) Modelling long-term evolution of chitotriosidase in non-neuronopathic Gaucher disease. Scandinavian Journal of Clinical and Laboratory Investigation 77:4, pages 275-282.
Read now
Read now
Cristina Drugan, Tudor C. Drugan, Nicolae Miron, Paula Grigorescu-Sido, Ioana Naşcu & Cristina Cătană. (2016) Evaluation of neopterin as a biomarker for the monitoring of Gaucher disease patients. Hematology 21:6, pages 379-386.
Read now
Read now
Sawa Ito & A. John Barrett. (2013) Gauchers Disease—A Reappraisal of Hematopoietic Stem Cell Transplantation. Pediatric Hematology and Oncology 30:2, pages 61-70.
Read now
Read now
Articles from other publishers (18)
Eline C.B. Eskes, Barbara Sjouke, Frédéric M. Vaz, Susan M.I. Goorden, André B.P. van Kuilenburg, Johannes M.F.G. Aerts & Carla E.M. Hollak. (2020) Biochemical and imaging parameters in acid sphingomyelinase deficiency: Potential utility as biomarkers. Molecular Genetics and Metabolism 130:1, pages 16-26.
Crossref
Crossref
Juliette Berger, Marie Vigan, Bruno Pereira, Thu Thuy Nguyen, Roseline Froissart, Nadia Belmatoug, Florence Dalbiès, Agathe Masseau, Christian Rose, Christine Serratrice, Yves-Marie Pers, Ivan Bertchansky, Fabrice Camou, Monia Bengherbia, Céline Bourgne, Catherine Caillaud, Magali Pettazzoni, Amina Berrahal, Jérôme Stirnemann, France Mentré & Marc G. Berger. (2018) Intra-monocyte Pharmacokinetics of Imiglucerase Supports a Possible Personalized Management of Gaucher Disease Type 1. Clinical Pharmacokinetics 58:4, pages 469-482.
Crossref
Crossref
. 2016. Diagnostic Imaging: Musculoskeletal Non-Traumatic Disease. Diagnostic Imaging: Musculoskeletal Non-Traumatic Disease
872
875
.
Neal J. Weinreb, David N. Finegold, Eleanor Feingold, Zhen Zeng, Barry E. Rosenbloom, Suma P. Shankar & Dominick Amato. (2015) Evaluation of disease burden and response to treatment in adults with type 1 gaucher disease using a validated disease severity scoring system (DS3). Orphanet Journal of Rare Diseases 10:1.
Crossref
Crossref
Marta Moskot, Joanna Jakóbkiewicz-Banecka, Elwira Smolińska, Bogdan Banecki, Grzegorz Węgrzyn & Magdalena Gabig-Cimińska. (2015) Activities of genes controlling sphingolipid metabolism in human fibroblasts treated with flavonoids. Metabolic Brain Disease 30:5, pages 1257-1267.
Crossref
Crossref
Amira Abdel Moneam Adly, Eman Abdel Rahman Ismail & Taghreed Mahmoud Ibraheem. (2015) Macrophage-derived soluble CD163 level in young patients with Gaucher disease: Relation to phenotypes, disease severity and complications. International Immunopharmacology 24:2, pages 416-422.
Crossref
Crossref
Irena Žnidar, Tanya Collin-Histed, Pascal Niemeyer, Johanna Parkkinen, Anne-Grethe Lauridsen, Sandra Zariņa, Yossi Cohen & Jeremy Manuel. (2014) The European Gaucher Alliance: a survey of member patient organisations’ activities, healthcare environments and concerns. Orphanet Journal of Rare Diseases 9:1.
Crossref
Crossref
L. van Dussen, E. J. Hendriks, J. E. M. Groener, R. G. Boot, C. E. M. Hollak & J. M. F. G. Aerts. (2014) Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy. Journal of Inherited Metabolic Disease 37:6, pages 991-1001.
Crossref
Crossref
Arndt Rolfs, Anne-Katrin Giese, Ulrike Grittner, Daniel Mascher, Deborah Elstein, Ari Zimran, Tobias Böttcher, Jan Lukas, Rayk Hübner, Uta Gölnitz, Anja Röhle, Ales Dudesek, Wolfgang Meyer, Matthias Wittstock & Hermann Mascher. (2013) Glucosylsphingosine Is a Highly Sensitive and Specific Biomarker for Primary Diagnostic and Follow-Up Monitoring in Gaucher Disease in a Non-Jewish, Caucasian Cohort of Gaucher Disease Patients. PLoS ONE 8:11, pages e79732.
Crossref
Crossref
Simon Jones. 2013. Stem Cell Therapy in Lysosomal Storage Diseases. Stem Cell Therapy in Lysosomal Storage Diseases
21
35
.
Filippo Vairo, Cristina Netto, Alicia Dorneles, Suzana Mittelstadt, Matheus Wilke, Divair Doneda, Kristiane Michelin, Camila Blos Ribeiro, Amanda Quevedo, Tatiane Vieira, Tatiele Nalin, Sônia Lueska & Ida Vanessa D. Schwartz. 2013. JIMD Reports - Volume 11. JIMD Reports - Volume 11
1
6
.
Carla E. M. Hollak, Nadia Belmatoug, J. Alexander Cole, Stephan vom Dahl, Patrick B. Deegan, Jack Goldblatt, Barry Rosenbloom, Laura van Dussen, Anna Tylki‐Szymańska, Neal J. Weinreb, Ari Zimran & Maria Domenica Cappellini. (2012) Characteristics of type I Gaucher disease associated with persistent thrombocytopenia after treatment with imiglucerase for 4–5 years. British Journal of Haematology 158:4, pages 528-538.
Crossref
Crossref
Ozlem Goker-Alpan. (2011) Therapeutic approaches to bone pathology in Gaucher disease: Past, present and future. Molecular Genetics and Metabolism 104:4, pages 438-447.
Crossref
Crossref
Eman M Sherif, Azza AG Tantawy, Amira AM Adly, Hossam A Kader & Eman AR Ismail. (2011) D-dimer assay in Egyptian patients with Gaucher disease: correlation with bone and lung involvement. Blood Coagulation & Fibrinolysis 22:3, pages 176-184.
Crossref
Crossref
Zahava R.S. Rosenberg-Yunger, Abdallah S. Daar, Halla Thorsteinsdóttir & Douglas K. Martin. (2011) Priority setting for orphan drugs: An international comparison. Health Policy 100:1, pages 25-34.
Crossref
Crossref
Stephan vom Dahl & Eugen Mengel. (2010) Lysosomal storage diseases as differential diagnosis of hepatosplenomegaly. Best Practice & Research Clinical Gastroenterology 24:5, pages 619-628.
Crossref
Crossref
You-Hai Xu, Ying Sun, Sonya Barnes & Gregory A. Grabowski. (2010) Comparative Therapeutic Effects of Velaglucerase Alfa and Imiglucerase in a Gaucher Disease Mouse Model. PLoS ONE 5:5, pages e10750.
Crossref
Crossref
M.H. de Ru, F.A. Wijburg, J.M.F.G. Aerts, E.D.M. Post & C.E.M. Hollak. (2012) Anemie, trombocytopenie en hepatosplenomegalie: de ziekte van Gaucher. Tijdschrift voor Kindergeneeskunde 78:2, pages 73-77.
Crossref
Crossref